A field trial to assess a blood-stage malaria vaccine
MA Thera, OK Doumbo, D Coulibaly… - … England Journal of …, 2011 - Mass Medical Soc
Background Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
A field trial to assess a blood-stage malaria vaccine.
MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - 2011 - cabidigitallibrary.org
Background: Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
[引用][C] A Field Trial to Assess a Blood-Stage Malaria Vaccine
MA THERA, OK DOUMBO, DA DIALLO… - The New England …, 2011 - pascal-francis.inist.fr
A Field Trial to Assess a Blood-Stage Malaria Vaccine CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
A field trial to assess a blood-stage malaria vaccine.
MA Thera, OK Doumbo, D Coulibaly… - The New England …, 2011 - europepmc.org
Background Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02 (A), a recombinant protein based on apical membrane …
malaria vaccine FMP2. 1/AS02 (A), a recombinant protein based on apical membrane …
[引用][C] A Field Trial to Assess a Blood-Stage Malaria Vaccine
MA Thera, OK Doumbo, D Coulibaly… - New England Journal …, 2011 - cir.nii.ac.jp
A Field Trial to Assess a Blood-Stage Malaria Vaccine | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] A Field Trial to Assess a Blood-Stage Malaria Vaccine
MA Thera, OK Doumbo, D Coulibaly, MB Laurens - N Engl J Med, 2011 - academia.edu
Background Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02a, a recombinant protein based on apical membrane antigen …
malaria vaccine FMP2. 1/AS02a, a recombinant protein based on apical membrane antigen …
A field trial to assess a blood-Stage malaria vaccine
MA Thera, OK Doumbo, D Coulibaly… - New England Journal …, 2011 - shs.hal.science
BACKGROUND--Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
A field trial to assess a blood-Stage malaria vaccine
MA Thera, OK Doumbo, D Coulibaly… - New England Journal …, 2011 - hal.science
BACKGROUND--Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
malaria vaccine FMP2. 1/AS02A, a recombinant protein based on apical membrane antigen …
[HTML][HTML] A Field Trial to Assess a Blood-Stage Malaria Vaccine
MA Thera, OK Doumbo, D Coulibaly… - The New England …, 2011 - ncbi.nlm.nih.gov
BACKGROUND Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02 A, a recombinant protein based on apical membrane antigen …
malaria vaccine FMP2. 1/AS02 A, a recombinant protein based on apical membrane antigen …
A field trial to assess a blood-stage malaria vaccine
MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - 2011 - pubmed.ncbi.nlm.nih.gov
Background Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2. 1/AS02 (A), a recombinant protein based on apical membrane …
malaria vaccine FMP2. 1/AS02 (A), a recombinant protein based on apical membrane …